New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
15th February 2023
US - Oregon: The Oregon Liquor and Cannabis Commission (OLCC) has expanded a recall on cannabis vaping products for containing artificially-derived CBN and synthetic CBC. The recall affects ten product lines, 7,000 sold units, and 500 products still on the market under the Firefly Extracts and Smoke-Rite Wellness brands.
22nd November 2022
US - Oregon: Governor Kate Brown has announced that she is issuing pardons for certain convictions for simple possession of cannabis prior to the state’s legalisation of recreational cannabis. It is estimated that the pardons will affect around 45,000 people and forgive more than $14m in fees and fines.
25th August 2022
US - Oregon: The Oregon Liquor and Cannabis Commission (OLCC) and Curaleaf have reached an agreement whereby the company will pay a fine of $130,000 and have its licence suspended for 23 days for mistakenly labelling some of its THC products as CBD products, press reports. The agreement comes after regulators originally imposed a fine of $200,000 and a 70-day suspension. Curaleaf has been the subject of several lawsuits over the mistake.
1st July 2022
8th April 2022
5th April 2022
US - Oregon: House Bill 4016 has been signed into law by governor Kate Brown. The new law allows the Oregon Liquor and Cannabis Commission to refuse to issue new cannabis production, processing, wholesale and retail licences “based on supply of and demand for marijuana”. Any moratorium on issuing licences, however, does not apply to licence renewals.
14th March 2022
3rd March 2022
3rd March 2022
23rd February 2022
Oregon: House Bill 4016 has been passed by the House and now heads to the Senate. The bill would allow the Oregon Liquor and Cannabis Commission to refuse to issue new cannabis production, processing, wholesale and retail licences “based on supply of and demand for marijuana”. Any moratorium on issuing licences, however, would not apply to renewals.
18th February 2022
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.